LIFE SAVER BUT SIGHT TAKER: STEROID INDUCED CSCR IN COVID 19 INFECTION.-Reference-Cited by-同舟云学术

LIFE SAVER BUT SIGHT TAKER: STEROID INDUCED CSCR IN COVID 19 INFECTION.

Published:2022-02-01 Issue: Volume: Page:5-6
ISSN:
Container-title:INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH
language:en
Short-container-title:ijsr

Author:

S. Date Purva¹,Bhalgat Sanchit²,Shah Neha²,B. Ingole Avinash³

Affiliation:

1. DNB, FVRS, Assistant Professor, Department of Ophthalmology, T.N.M.C. BYL Nair Ch. Hospital, Mumbai Central. Mumbai, Maharashtra, India.

2. DOMS, DNB, Fellow Vitreo-retina surgery, Department of Ophthalmology, T.N.M.C. BYL Nair Ch. Hospital, Mumbai Central. Mumbai, Maharashtra, India.

3. MS, Professor, Department of Ophthalmology, T.N.M.C. BYL Nair Ch. Hospital, Mumbai Central. Mumbai, Maharashtra, India.

Abstract

Introduction:COVID-19 pandemic has multiple ocular manifestations. We report 2 cases of central serous chorioretinopathy, following COVID19 infection. Case Presentation: We diagnosed two middle aged patients with central serous chorioretinopathy one week post COVID-19 infection. Both patients were admitted in COVID-19 ward. Case 1 was a male diabetic and required ventilator assisted respiration. Case 2 was a female patient with no systemic diseases. Both patients were given intravenous (IV) methylprednisolone for 2 weeks followed by oral prednisolone. Case 1developed CSCR in right eye while the other patient developed CSCR in both eyes. Conclusion: The possibility of developing CSCR should be kept in mind by the treating physician in Covid 19 patients treated with steroids. Early involvement of ophthalmologist can lead to timely and effective management of same

Publisher

World Wide Journals

Reference5 articles.

1. Yang W, Cao Q, Qin L, Wang X, Cheng Z, Pan A, et al. Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19):A multi-center study in Wenzhou city, Zhejiang, China. J Infect. 2020 Apr;80(4):388–93.

2. Sen M, Honavar S, Sharma N, Sachdev M. COVID-19 and Eye: A Review of Ophthalmic Manifestations of COVID-19. Indian J Ophthalmol. 2021;69(3):488.

3. Shah S, Desai M, Desai C, Dikshit R. Steroid-induced central serous retinopathy. Indian J Pharmacol. 2011;43(5):607.

4. Nicholson B, Noble J, Forooghian F, Meyerle C. Central Serous Chorioretinopathy: Update on Pathophysiology and Treatment. Surv Ophthalmol. 2013 Mar;58(2):103–26.

5. Tittl MK, Spaide RF, Wong D, Pilotto E, Yannuzzi LA, Fisher YL, et al. Systemic Findings Associated With Central Serous Chorioretinopathy. Am J Ophthalmol. 1999;128(1):6.